用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-22-039682 Act: 34 Size: 167 KB 网页链接
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000921895-22-002865 Act: 34 Size: 134 KB 网页链接
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000921895-22-002830 Act: 34 Size: 137 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001193125-22-260698 Act: 34 Size: 171 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-22-023693 Size: 5 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-22-023692 Size: 4 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-22-023690 Size: 4 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, item 8.01 Accession Number: 0001193125-22-255752 Act: 34 Size: 337 KB 网页链接
$美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-255753 Act: 34 Size: 149 KB 网页链接
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000921895-22-002663 Act: 34 Size: 135 KB 网页链接